• News

"Arcutis’ Roflumilast Cream Could Be “Game Changer” for Plaque Psoriasis"

  • Practical Dermatology
  • New York, NY
  • (July 15, 2020)


Arcutis Biotherapeutics, Inc.’s Roflumilast cream (ARQ-151) produced significant improvements in patients with plaque psoriasis in as early as two weeks, according to a results from a phase 2b trial published in The New England Journal of Medicine.

Learn more